Aptorum Group (APM) Competitors $0.88 +0.01 (+0.61%) Closing price 03/28/2025 03:58 PM EasternExtended Trading$0.88 0.00 (-0.11%) As of 03/28/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock APM vs. INAB, MTEX, CLRB, SNTI, EDSA, BCAB, CMMB, BFRG, ELEV, and NXTCShould you be buying Aptorum Group stock or one of its competitors? The main competitors of Aptorum Group include IN8bio (INAB), Mannatech (MTEX), Cellectar Biosciences (CLRB), Senti Biosciences (SNTI), Edesa Biotech (EDSA), BioAtla (BCAB), Chemomab Therapeutics (CMMB), Bullfrog AI (BFRG), Elevation Oncology (ELEV), and NextCure (NXTC). These companies are all part of the "pharmaceutical products" industry. Aptorum Group vs. IN8bio Mannatech Cellectar Biosciences Senti Biosciences Edesa Biotech BioAtla Chemomab Therapeutics Bullfrog AI Elevation Oncology NextCure Aptorum Group (NASDAQ:APM) and IN8bio (NASDAQ:INAB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, community ranking, risk, institutional ownership and media sentiment. Which has more risk and volatility, APM or INAB? Aptorum Group has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Comparatively, IN8bio has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. Do institutionals & insiders hold more shares of APM or INAB? 3.8% of Aptorum Group shares are held by institutional investors. Comparatively, 92.1% of IN8bio shares are held by institutional investors. 64.0% of Aptorum Group shares are held by insiders. Comparatively, 15.5% of IN8bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media prefer APM or INAB? In the previous week, Aptorum Group had 1 more articles in the media than IN8bio. MarketBeat recorded 3 mentions for Aptorum Group and 2 mentions for IN8bio. Aptorum Group's average media sentiment score of 0.91 beat IN8bio's score of 0.44 indicating that Aptorum Group is being referred to more favorably in the media. Company Overall Sentiment Aptorum Group Positive IN8bio Neutral Does the MarketBeat Community believe in APM or INAB? Aptorum Group received 15 more outperform votes than IN8bio when rated by MarketBeat users. However, 74.29% of users gave IN8bio an outperform vote while only 68.33% of users gave Aptorum Group an outperform vote. CompanyUnderperformOutperformAptorum GroupOutperform Votes4168.33% Underperform Votes1931.67% IN8bioOutperform Votes2674.29% Underperform Votes925.71% Which has better valuation & earnings, APM or INAB? Aptorum Group has higher revenue and earnings than IN8bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptorum Group$430K10.67-$2.83MN/AN/AIN8bioN/AN/A-$30.01M-$0.58-0.34 Do analysts recommend APM or INAB? IN8bio has a consensus target price of $6.00, suggesting a potential upside of 2,959.66%. Given IN8bio's stronger consensus rating and higher probable upside, analysts plainly believe IN8bio is more favorable than Aptorum Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptorum Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00IN8bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is APM or INAB more profitable? Aptorum Group's return on equity of 0.00% beat IN8bio's return on equity.Company Net Margins Return on Equity Return on Assets Aptorum GroupN/A N/A N/A IN8bio N/A -197.15%-130.48% SummaryAptorum Group beats IN8bio on 9 of the 14 factors compared between the two stocks. Remove Ads Get Aptorum Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APM vs. The Competition Export to ExcelMetricAptorum GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.59M$6.90B$5.63B$7.84BDividend YieldN/A2.77%5.33%4.01%P/E RatioN/A7.2623.6018.74Price / Sales10.67218.62388.2390.77Price / CashN/A65.6738.1734.64Price / Book0.306.386.894.23Net Income-$2.83M$142.34M$3.20B$247.47M7 Day Performance-3.80%-5.15%-3.06%-2.29%1 Month Performance-6.84%-7.55%1.52%-5.81%1 Year Performance-90.67%-11.06%9.37%-0.96% Aptorum Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APMAptorum Group1.5563 of 5 stars$0.89+0.6%N/A-90.7%$4.59M$430,000.000.0030Short Interest ↓News CoverageINABIN8bio3.031 of 5 stars$0.23-2.1%$6.00+2,532.7%-83.4%$18.52MN/A-0.3020Short Interest ↑MTEXMannatech0.6989 of 5 stars$9.62-0.8%N/A+7.4%$18.13M$121.55M-11.88250Earnings ReportAnalyst ForecastGap UpCLRBCellectar Biosciences2.0419 of 5 stars$0.39+5.7%$17.67+4,427.6%-91.6%$17.98MN/A-0.2310Analyst ForecastShort Interest ↑SNTISenti Biosciences3.6819 of 5 stars$3.72+1.1%$10.00+168.8%-9.0%$17.97M$2.56M-0.244Short Interest ↓Positive NewsGap UpEDSAEdesa Biotech3.5885 of 5 stars$2.56+2.4%$21.00+720.3%-40.4%$17.90MN/A-1.3720Positive NewsBCABBioAtla2.3288 of 5 stars$0.37+5.4%$6.00+1,521.6%-89.1%$17.89M$11M-0.2260Earnings ReportShort Interest ↑News CoverageGap DownCMMBChemomab Therapeutics3.4656 of 5 stars$1.24-3.1%$9.00+625.8%+45.1%$17.81MN/A-1.2420Short Interest ↓News CoverageBFRGBullfrog AI1.3542 of 5 stars$1.89+7.4%N/A-47.0%$17.79M$60,000.00-2.224Upcoming EarningsShort Interest ↓Positive NewsELEVElevation Oncology2.6146 of 5 stars$0.29-3.4%$3.39+1,067.5%-94.9%$17.17MN/A-0.3540NXTCNextCure4.5287 of 5 stars$0.61+6.8%$3.50+474.7%-77.6%$17.06MN/A-0.2990Gap Up Remove Ads Related Companies and Tools Related Companies INAB Competitors MTEX Competitors CLRB Competitors SNTI Competitors EDSA Competitors BCAB Competitors CMMB Competitors BFRG Competitors ELEV Competitors NXTC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APM) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptorum Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptorum Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
